Pacira Pharmaceuticals reported $721.88M in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Aerie Pharmaceuticals AERI:US $ 312.13M 0.45M
Amerisourcebergen ABC:US $ 4640.13M 6.58M
Astellas Pharma 4503:JP Y 111621M 15735M
Bristol Myers Squibb BMY:US $ 37107M 343M
Cara Therapeutics CARA:US $ 0 0
Depomed DEPO:US $ 49.5M 11.75M
Horizon Pharma HZNP:US $ 2550.99M 1.75M
Ironwood Pharmaceuticals IRWD:US $ 395.45M 0.4M
JAZZ PHA JAZZ:US $ 5990M 2.87M
Lannett LCI:US $ 614.95M 4.87M
Nektar Therapeutics NKTR:US $ 0M 0M
Omeros OMER:US $ 314.36M 454K
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Perrigo Ordinary Shares PRGO:US $ 4086.1M 575.5M
Revance Therapeutics RVNC:US $ 378.38M 52.48M
Supernus Pharmaceuticals SUPN:US $ 0M 400.38M
Teva Pharmaceutical TEVA:IT 20.36B 477M
Xeris Pharmaceuticals Inc XERS:US $ 138.07M 429K
Xoma XOMA:US $ 0 0
Zoetis ZTS:US $ 5221M 7M